Skip to main content
Premium Trial:

Request an Annual Quote

Revenues and Earnings Up for Thermo Electron in Q1

NEW YORK, April 28 (GenomeWeb News) - Thermo Electron yesterday reported increased revenues and earnings for the first quarter.


Revenues for the quarter were $582 million, up from $500.2 million during the same period last year. The Life and Laboratory Sciences segment, which includes mass spectrometers for proteomics, reported $365 million in revenues, up from $299 during the year-ago period. Thermo attributed the revenue growth in this segment mainly to strong sales of mass spectrometry and spectroscopy instruments.


Research and development expenses climbed slightly, to $39.8 million, from $37.3 million during last year's first quarter.


Earnings for the quarter were $43.1 million, or $.26 per share, up from $36.4 million, or $.22 per share, during the year-ago period.


As of April 3, Thermo had $353 million in cash and cash equivalents, and $91 million in short-term investments.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.